ZWBC yields 1000000.00% · PFE yields 6.13%● Live data
📍 ZWBC pulled ahead of the other in Year 1
Combined, ZWBC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZWBC + PFE for your $10,000?
GoldKey Corporation researches and develops, and sells networking and security products worldwide. It offers GoldKey Security Tokens that are used to securely authenticate, encrypt, and share sensitive information on computers, servers, and mobile devices, as well as in the cloud; and GoldKey secure portal, a rack-mount unit, which installs into a customer's data center to provide secure access protection to existing Web servers, as well as to create secure cloud storage on existing customer storage servers. The company also provides GoldKey master tokens that offer access to data encrypted by users in their organization; create and manage groups; reset GoldKey personalization data, such as the PIN; and duplicate GoldKeys. In addition, it provides GoldKey Vaults, an encrypted cloud storage service; GoldKey Mail, an encrypted cloud-based email system for businesses; and GoldKey Security Tokens, a solution to eliminate username and password-based authentication for two-factor authentication on air gapped computers and networks. Further, the company offers GoldKey Authentication, a secure sign in service; GoldKey Backup, an encrypted, off-site, and automated backup system that helps organizations in preventing loss of important files; and Data Center, a portal management service. It serves federal, state, and local government agencies; financial institutions, schools, and universities; and a range of security-conscious enterprises and individuals. The company was formerly known as WideBand Corporation and changed its name to GoldKey Corporation in December 2014. GoldKey Corporation is based in Gallatin, Missouri.
Full ZWBC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.